Authors
Loading...
Assessment of serum metabolic profiles during chemotherapy in AML patients shows distinct changes, indicating potential biomarkers for drug resistance.
Hu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: